Blood sugar tracker for pregnancy diabetes: does your background matter?

NCT ID NCT06436326

Recruiting now Disease control Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether wearing a continuous glucose monitor (CGM) helps pregnant women with gestational diabetes control their blood sugar and improve outcomes for both mother and baby. Researchers will also examine how socioeconomic status, diet, and culture affect results. The trial involves 120 participants in Taiwan.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Continuous glucose monitor (Abbott FreeStyle Libre 2)
What this could lead to: If successful, this could show that continuous glucose monitoring helps manage gestational diabetes better, especially for women from different backgrounds.
What could go wrong: This is a small, early-stage study (120 participants) focused on observation and correlation, not a treatment trial. Results may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTINUOUS GLUCOSE MONITORING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONTINUOUS GLUCOSE MONITORING GESTATIONAL DIABETES MELLITUS

Contacts and locations

Locations

National Taiwan University Hospital Hsin-Chu Branch BioMedical Park Hospital
RECRUITING

Hsinchu, 302058, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.